tiprankstipranks
Advertisement
Advertisement

SLGL Stock Latest News

Sol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating
RatingsSol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating
7d ago
SLGL
Sol-Gel Technologies Posts Q2 Loss as Pivotal Gorlin Syndrome Trial Advances Toward Late-2026 Readout
PremiumCompany Announcements
Sol-Gel Technologies Posts Q2 Loss as Pivotal Gorlin Syndrome Trial Advances Toward Late-2026 Readout
7d ago
6K
SLGL
Maintains Buy Rating and $184 Price Target on SGT-610’s Promising Gorlin Syndrome Opportunity
PremiumRatings
Maintains Buy Rating and $184 Price Target on SGT-610’s Promising Gorlin Syndrome Opportunity
10d ago
SLGL
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
PremiumTipRanks Newswire
What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity
1M ago
PTN
CRNX
Sol-Gel Technologies initiated with an Outperform at Mizuho
PremiumThe Fly
Sol-Gel Technologies initiated with an Outperform at Mizuho
2M ago
SLGL
Sol-Gel Technologies initiated with a Buy at TD Cowen
PremiumThe FlySol-Gel Technologies initiated with a Buy at TD Cowen
3M ago
SLGL
Analyst Maintains Buy on Sol-Gel, Citing SGT-610 Progress and Solid Cash Runway with Unchanged $184 Price Target
Premium
Ratings
Analyst Maintains Buy on Sol-Gel, Citing SGT-610 Progress and Solid Cash Runway with Unchanged $184 Price Target
3M ago
SLGL
Sol-Gel Technologies reports Q1 EPS ($1.31) vs. ($3.20) last year
Premium
The Fly
Sol-Gel Technologies reports Q1 EPS ($1.31) vs. ($3.20) last year
3M ago
SLGL
Sol-Gel Extends Patidegib IP to 2044 and Bolsters Cash Runway With $33.1 Million Offering
PremiumCompany Announcements
Sol-Gel Extends Patidegib IP to 2044 and Bolsters Cash Runway With $33.1 Million Offering
3M ago
6K
SLGL
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610
PremiumCompany Announcements
Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610
5M ago
6K
SLGL
Sol-Gel Technologies 459K share Spot Secondary priced at $72.00
PremiumThe Fly
Sol-Gel Technologies 459K share Spot Secondary priced at $72.00
5M ago
SLGL
Sol Gel Technologies trading resumes
PremiumThe Fly
Sol Gel Technologies trading resumes
6M ago
SLGL
Sol Gel Technologies trading halted, volatility trading pause
PremiumThe FlySol Gel Technologies trading halted, volatility trading pause
6M ago
SLGL
Sol-Gel Technologies: Upside-Driven Buy on SGT-610’s Orphan Gorlin Syndrome Opportunity and Repriced Peak Sales Potential
Premium
Ratings
Sol-Gel Technologies: Upside-Driven Buy on SGT-610’s Orphan Gorlin Syndrome Opportunity and Repriced Peak Sales Potential
7M ago
SLGL
Sol-Gel Technologies price target raised to $110 from $50 at H.C. Wainwright
Premium
The Fly
Sol-Gel Technologies price target raised to $110 from $50 at H.C. Wainwright
7M ago
SLGL
Sol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
PremiumRatings
Sol-Gel: SGT-610 as Core Value Driver Underpins $50 Target and Buy Rating Despite Pipeline Setbacks
8M ago
SLGL
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
PremiumCompany Announcements
Sol-Gel Technologies Updates Clinical Pipeline Following Phase 1b Results
8M ago
6K
SLGL
Sol-Gel decides not to advance SGT-210 development in Darier disease
PremiumThe Fly
Sol-Gel decides not to advance SGT-210 development in Darier disease
8M ago
SLGL
One new option listing and fifteen option delistings on November 24th
PremiumThe Fly
One new option listing and fifteen option delistings on November 24th
9M ago
KG
SST
Sol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments
PremiumCompany AnnouncementsSol-Gel Technologies Announces Q3 2025 Financial Results and Strategic Developments
9M ago
6K
SLGL
Sol-Gel Technologies reports Q3 EPS ($2.13) vs (13c) last year
Premium
The Fly
Sol-Gel Technologies reports Q3 EPS ($2.13) vs (13c) last year
9M ago
SLGL
Sol-Gel Technologies Announces Key Leadership and Auditor Appointments
Premium
Company Announcements
Sol-Gel Technologies Announces Key Leadership and Auditor Appointments
10M ago
6K
SLGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >